PDC Therapeutics
Targeted Therapies with No Compromise
PDC Therapeutics is a clinically validated biotechnology start-up developing targeted Polymer-Drug Conjugate technologies that aim to provide patients with an optimal therapeutic index. PDC Therapeutics’ proprietary Sagitta biodegradable conjugation platforms help discover and develop therapies with no compromise.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
31.10.2025
More than 20 Swiss biotech companies to exhibit at Bio Europe (startupticker.ch)
Last Tweets
No milestones
No Jobs
No videos and documents
No Awards
PDC Therapeutics
Targeted Therapies with No Compromise
Website:
www.pdcbio.com
Headquarter:
Epalinges
Foundation Date:
November 2020
Technology:
- Biotech
Sectors:
- Antibodies
- Biotech
- Cancer
- Diagnostics
- Drug development platforms
- Drug discovery
- Nano technologies
- Research and development
- Protein drugs
- Small molecule drugs